Navigation Links
Schering-Plough Announces Sponsorship of Rabies-Control Projects in India
Date:11/2/2009

nd other animals.

About Schering-Plough

Schering-Plough is an innovation-driven, science-centered global health care company. Through its own biopharmaceutical research and collaborations with partners, Schering-Plough creates therapies that help save and improve lives around the world. The company applies its research-and-development platform to human prescription, animal health and consumer health care products. Schering-Plough's vision is to "Earn Trust, Every Day" with the doctors, patients, customers and other stakeholders served by its colleagues around the world. The company is based in Kenilworth, N.J., and its Web site is www.schering-plough.com.

Intervet/Schering-Plough Animal Health is a leader in research and dedicated to the development, production and marketing of innovative, high-quality animal-health products for all major farm and companion animal species. For more information about Intervet/Schering-Plough Animal Health visit: www.intervet.com and www.intervetusa.com.

About the Global Alliance for Rabies Control

The Global Alliance for Rabies Control is the foremost non-profit organization dedicated to eliminating rabies throughout the world. The mission of the Alliance is to promote rabies awareness and control. The organization contributes to support rabies control programs and educational initiatives.

The Global Alliance for Rabies and Control was established to bring together public and private expertise in the field of rabies, including medical, veterinary, wildlife and animal welfare agencies, to utilize a 'one medicine' approach to establish rabies prevention programs. The Alliance coordinates the World Rabies Day campaign and works alongside its partner institutions and organizations. (

SOURCE Schering-Plough Corporation
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5

Related medicine news :

1. WuXi AppTec Receives 2009 Schering-Plough Excellence Award
2. Video: Schering-Plough Announces FDA Approval of SAPHRIS(R) (asenapine) for Acute Treatment of Schizophrenia In Adults and Manic or Mixed Episodes of Bipolar I Disorder With or Without Psychotic Features In Adults
3. Schering-Plough Announces Resolution of Litigations on U.S. Marketing of Generic Forms of Solid Oral Dosage Forms of CLARINEX(R)
4. Schering-Plough to Webcast Special Meeting of Shareholders
5. Schering-Plough Reports Proposed Settlement in Litigation Involving Planned Merger with Merck
6. New Vaccine from Intervet/Schering-Plough Animal Health is First for Canine Influenza Virus
7. Schering-Plough Announces European Filing of SYCREST(R) (asenapine) for the Treatment of Schizophrenia and Bipolar I Disorder
8. Valeant Grants Schering-Plough Exclusive Option in Japan for Taribavirin in Exchange for Release of Last Right of Refusal
9. Johnson & Johnson Files Arbitration Demand Against Schering-Plough to Resolve Dispute Over Agreements for REMICADE(R) and SIMPONI(TM)
10. Video: Schering-Plough Introduces TINACTIN(R) CHILL, a Line of Antifungal Products Geared Specifically to Young Males
11. Schering-Plough Starts Patient Enrollment in Phase 3 Trial for Acadesine, an Investigational Agent Being Studied for Prevention of Complications From Cardiac Surgery
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/17/2014)... April 17, 2014 EcoHealth Alliance, a nonprofit organization ... published a comprehensive review today examining the current state ... The review calls for improved global surveillance strategies to ... recent outbreak of Ebola in West Africa that has ... of Guinea and Liberia. According to the World ...
(Date:4/17/2014)... to find a colored ribbon representing a disease. A pink ... color ribbon does one think of with lung cancer?, Although ... suffering from the disease, black may be the only one ... lung cancer patients, primarily smokers between the ages of 51 ... stigma often felt by these patients, the emotional toll it ...
(Date:4/17/2014)... of Canadians surveyed said they would participate in public ... of genetic conditions, only 80 per cent said they ... sequence their newborns, genomes.,Most newborns in North America have ... two of life in which a tiny amount of ... about five to 54 conditions, depending on the state ...
(Date:4/16/2014)... , STANFORD, Calif. Consider the marvel of the embryo. ... shape and function as they multiply to become the cells ... tissues of the body. , Now, in a feat of ... the complex genetic coding that allows embryonic cells to proliferate ...
(Date:4/16/2014)... fertility treatments are the leading cause of increases in ... of premature birth, these results are not inevitable, concludes ... . The article identifies six changes in policy and ... and prematurity, including expanding insurance coverage for in vitro ...
Breaking Medicine News(10 mins):Health News:Re-emergence of Ebola focuses need for global surveillance strategies 2Health News:Re-emergence of Ebola focuses need for global surveillance strategies 3Health News:Unraveling the 'black ribbon' around lung cancer 2Health News:Researcher looks at public perceptions around newborn testing 2Health News:Researcher looks at public perceptions around newborn testing 3Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 2Health News:Stanford scientists develop 'playbook' for reverse engineering tissue 3Health News:Preterm births, multiples, and fertility treatment 2Health News:Preterm births, multiples, and fertility treatment 3
... Transcept,Pharmaceuticals, Inc. today announced that Glenn A. Oclassen, ... 2008 Merrill Lynch Global,Pharmaceutical, Biotechnology and Medical Device ... City on Tuesday, February 5, 2008 at 8:40 ... Pharmaceuticals, Inc. is a specialty pharmaceutical company,deriving significant ...
... Feel Their Overall Health Affects Their,Recovery from Schizophrenia, ... Health,America of San Diego today released results of ... in mental health settings from the,perspective of both ... both groups are aware of actions to improve ...
... Baby Products, With Information, on the Best Baby Products and Easy-To-Follow ... ... Well, NORCROSS, Georgia, January 29 BabySupply.Info, has,launched today ... opportunity to save time and,money with a shopping comparison engine for baby ...
... Cause To Support Stefanie LaRue and Her Fight to,Live, ... cancer survivor Stefanie LaRue, known nationally as the "Breast,Cancer ... breast,cancer, is being honored at a benefit concert on ... at 2701 N. Sepulveda Blvd., Los,Angeles, CA. The event, ...
... billion -- Diluted earnings per share from continuing operations increase 16,percent ... ... -- Full year Non-GAAP EPS now expected to be $3.75 ... contract, DUBLIN, Ohio, Jan. 29 Cardinal Health, a,global provider of ...
... CHICAGO, Jan. 29 Medifacts Systems, Inc. announces ... genetic test patent to Mayo,Clinic. The patented test ... of blood-related disorders. The patent is the invention ... Vicksburg, Mississippi who,was educated at Xavier University in ...
Cached Medicine News:Health News:Transcept Pharmaceuticals to Present at the 2008 Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference 2Health News:First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia 2Health News:First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia 3Health News:First-of-Its-Kind National Online Survey Uncovers Obstacles to Comprehensive Healthcare for People With Schizophrenia 4Health News:BabySupply.Info Announces Launch of Website for New Parents 2Health News:32-Year-Old Breast Cancer Survivor, Fashion Model Featured in Benefit Concert 'Music of the Light' at Skirball Cultural Center 2Health News:32-Year-Old Breast Cancer Survivor, Fashion Model Featured in Benefit Concert 'Music of the Light' at Skirball Cultural Center 3Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 2Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 3Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 4Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 5Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 6Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 7Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 8Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 9Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 10Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 11Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 12Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 13Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 14Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 15Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 16Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 17Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 18Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 19Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 20Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 21Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 22Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 23Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 24Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 25Health News:Cardinal Health Reports Second Quarter Results, Revises EPS Outlook 26Health News:Medifacts Systems, Inc. Grants Exclusive License for Genetic Test Patent to Mayo Clinic 2Health News:Medifacts Systems, Inc. Grants Exclusive License for Genetic Test Patent to Mayo Clinic 3
(Date:1/15/2014)... Calif. , Jan. 15, 2014 Massachusetts ... (NASDAQ: AMGN ) announced today that ... discover and validate new therapeutic targets and develop ... chronic disorder that affects millions worldwide. The MGH-Broad-Amgen ...
(Date:1/15/2014)... BEACH GARDENS, Fla. , Jan. 15, 2014  In an unprecedented ... difficile and TB in ambulances and other transport vehicles, an advanced ... used by rescue personnel for the first time. ... in contact with these deadly pathogens, West Palm Beach ...
(Date:1/15/2014)... 2014  According to Millennium Research Group (MRG), the ... the United States and European ... expand moderately through 2022, with embolization particles representing ... interest in drug-eluting beads (DEBs) and radioembolization spheres ...
Breaking Medicine Technology:Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 2Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 3Mass. General, Broad Institute and Amgen Will Work to Discover New Drugs for Inflammatory Bowel Disease 4Superbugs No Longer Ride In Rescue Vehicles 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 2US and European Transcatheter Embolization and Occlusion Device Market to Surpass $1.6 Billion by 2022 3
... Fla., March 22, 2011 GeNO LLC ( ... company, today announced commencement of  the PHiano Study: ... of Pulmonary Hypertension in patients with Pulmonary Arterial ... Pulmonary Fibrosis (PH-IPF) using Inhaled NITROSYL™ nitric oxide ...
... Dry, dull skin can get you down in the ... professor and chair of the department of dermatology at Wake ... AmLactin® twice a day, seven days a week to get ... clinically proven alpha-hydroxy acid, 12% lactic acid, to gently exfoliate ...
Cached Medicine Technology:GeNO LLC Initiates Study of Inhaled NITROSYLâ„¢ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 2GeNO LLC Initiates Study of Inhaled NITROSYLâ„¢ Nitric Oxide in Idiopathic Pulmonary Fibrosis (PH-IPF) and Pulmonary Arterial Hypertension (PAH) Patients 3Does Your Skin Need Therapy? 2Does Your Skin Need Therapy? 3